Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Lomaestro

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2007
Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategyThomas P Lodise, Ben Lomaestro, George L Drusano
Antimicrobial Agents and Chemotherapy|August 19, 2015
Optimizing the initial amikacin dosage in adultsBryan P White, Ben Lomaestro, Manjunath P Pai
Pharmacotherapy|September 16, 2014
Vancomycin-associated renal dysfunction: where are we now?Joseph J Carreno, Rachel M Kenney, Ben Lomaestro
Pharmacotherapy|June 18, 2002
Concomitant administration of drugs known to decrease the systemic availability of gatifloxacinJennifer Bowes, Eileen M Graffunder, Ben Lomaestro, et al.
International Journal of Antimicrobial Agents|August 14, 2018
Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapyJoseph Carreno, Tori Smiraglia, Christopher Hunter, et al.
Antimicrobial Agents and Chemotherapy|March 15, 2017
Pilot Study of a Bayesian Approach To Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic SamplingJoseph J Carreno, Ben Lomaestro, John Tietjan, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2008
Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicityThomas P Lodise, Ben Lomaestro, Jeffrey Graves, et al.
Pharmacotherapy|September 11, 2013
Vancomycin dosing in children and young adults: back to the drawing boardLauren Camaione, Kimberly Elliott, Amy Mitchell-Van Steele, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulationThomas P Lodise, Ben Lomaestro, Keith A Rodvold, et al.
Pharmacotherapy|October 30, 2007
Effects of gatifloxacin and levofloxacin on rates of hypoglycemia and hyperglycemia among elderly hospitalized patientsThomas Lodise, Jeffrey Graves, Chris Miller, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2007
Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategyThomas P Lodise, Ben Lomaestro, George L Drusano
Antimicrobial Agents and Chemotherapy|August 19, 2015
Optimizing the initial amikacin dosage in adultsBryan P White, Ben Lomaestro, Manjunath P Pai
Pharmacotherapy|September 16, 2014
Vancomycin-associated renal dysfunction: where are we now?Joseph J Carreno, Rachel M Kenney, Ben Lomaestro
Pharmacotherapy|June 18, 2002
Concomitant administration of drugs known to decrease the systemic availability of gatifloxacinJennifer Bowes, Eileen M Graffunder, Ben Lomaestro, et al.
International Journal of Antimicrobial Agents|August 14, 2018
Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapyJoseph Carreno, Tori Smiraglia, Christopher Hunter, et al.
Antimicrobial Agents and Chemotherapy|March 15, 2017
Pilot Study of a Bayesian Approach To Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic SamplingJoseph J Carreno, Ben Lomaestro, John Tietjan, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2008
Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicityThomas P Lodise, Ben Lomaestro, Jeffrey Graves, et al.
Pharmacotherapy|September 11, 2013
Vancomycin dosing in children and young adults: back to the drawing boardLauren Camaione, Kimberly Elliott, Amy Mitchell-Van Steele, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulationThomas P Lodise, Ben Lomaestro, Keith A Rodvold, et al.
Pharmacotherapy|October 30, 2007
Effects of gatifloxacin and levofloxacin on rates of hypoglycemia and hyperglycemia among elderly hospitalized patientsThomas Lodise, Jeffrey Graves, Chris Miller, et al.
Pageof 2